title: 0.1% Polyhexanide-Betaine Solution as an Adjuvant in a Case-Series of Chronic Wounds.
abstract: The application of 0.1% polyhexanide-betaine gel and irrigating solution was used in place of saline during standard of care wound treatment for 70 chronic wounds of various etiologies. Our goal in this study sample was to investigate the number of days to wound closure, change in absolute wound size, and antimicrobial initiation from baseline visit, following application of polyhexanide-betaine in standard of care wound treatment. Results suggested a benefit of Prontosan® (Polyhexanide-betaine, B. Braun Medical Inc., Allentown, Pennsylvania), with very few patients being administered supplemental antibiotic treatment.
  
  
  
  A retrospective chart analysis evaluated 0.1% polyhexanide-betaine as an adjuvant in the management of chronic non-healing wounds. Over a two-year period at a single wound center, 0.1% polyhexanide-betaine gel and irrigating solution were applied in place of saline during standard of care wound treatment for 70 chronic wounds of various etiologies. Standard weekly wound protocols and debridement were performed. All wounds were evaluated for days to closure, change in wound dimensions, and number of patients requiring antibiotic therapy after initial consultation at the study site.
  
  
  
  A case series of 49 patients presented 70 wounds for analysis. Antimicrobial therapy was initiated in five of 49 patients. Days to wound closure revealed that venous wounds showed the shortest number of days to closure (29 days) with diabetic ulcers the longest (92 days). Significant comorbid conditions and concomitant medications were present in all groups and did not appear associated with closure rates.
  
  
  
  The use of 0.1% polyhexanide-betaine gel and solution in treating chronic non-healing wounds provided a moist wound healing environment facilitating closure. Of particular note was the fact that with polyhexanide-betaine, antimicrobial therapy was not initiated in nearly 90% of patients. It is theorized that the antimicrobial effect of 0.1% polyhexanide-betaine gel and solution inhibited bacterial colonization and reduced the need for antimicrobial usage. A prospective controlled and randomized study is warranted to further explore this theory.
authors: Wound Institute and Research Center, Dunmore, Pennsylvania.
authors: Michael
authors: M
authors: Moore
authors: Wound Institute and Research Center, Dunmore, Pennsylvania.
authors: Nanci
authors: N
authors: Dobson
authors: B. Braun Medical Inc., Allentown, Pennsylvania.
authors: Wes
authors: W
authors: Cetnarowski
mesh_terms: D001622:Betaine / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use*; D002908:Chronic Disease; D004202:Disinfectants / Q000627:therapeutic use*; D006801:Humans; D011446:Prospective Studies; D012189:Retrospective Studies; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D001645:Biguanides; D004202:Disinfectants; C031233:polihexanide; D001622:Betaine